Live Breaking News & Updates on டிஜிட்டல் மாநாடு|Page 19
Stay updated with breaking news from டிஜிட்டல் மாநாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Heat Biologics to Present at 2021 BIO CEO & Investor Digital Conference theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Loki Therapeutics to Present at BIO CEO & Investor Digital Conference News provided by Share this article Share this article LONG ISLAND CITY, N.Y., Feb. 11, 2021 /PRNewswire/ Loki Therapeutics, an immuno-oncology company developing next-generation cancer therapeutics that leverage childhood vaccination recall antigens, announced today its Chief Executive Officer Chris Bradley will present at the BIO CEO & Investor Digital Conference taking place February 16-18, 2021. The presentation will be available on demand during the virtual event for all registered attendees. During the presentation, Mr. Bradley will provide an overview of the Company s business and clinical development programs and discuss anticipated 2021 milestones. Additionally, Mr. Bradley will be participating in virtual one-on-one meetings with registered investors and pharmaceutical companies. ....
/PRNewswire/ Cytocom, Inc., a leading biopharmaceutical company creating second generation immune therapies, announced today that Mike Handley, President. ....
Press release content from Globe Newswire. The AP news staff was not involved in its creation. ORYZON to Present New Clinical Data and Corporate Updates at Conferences in February and March Oryzon Genomics, S.A.February 10, 2021 GMT 2021 BIO CEO & Investor Digital Conference 15th International Conference on Alzheimer’s and Parkinson’s Diseases AD/PD 2021 H.C. Wainwright Global Life Sciences Conference BioCapital Europe 2021 33rd Annual ROTH Conference MADRID, Spain and CAMBRIDGE, Mass., Feb. 10, 2021 (GLOBE NEWSWIRE) Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announces that it will present new clinical data and attend several industry conferences in February and March, all in virtual format due to the Covid-19 pandemic. ....
Soligenix to Present at the 2021 BIO CEO & Investor Digital Conference News provided by Share this article Share this article PRINCETON, N.J., Feb. 11, 2021 /PRNewswire/ Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that its President and Chief Executive Officer, Christopher J. Schaber, PhD, will deliver a corporate presentation at the BIO CEO & Investor Digital Conference taking place February 16-18, 2021. The presentation will be available to registered conference attendees for on-demand viewing beginning February 15, 2021 at 9:00 AM EST via the virtual conference link. Alternatively, an audio webcast of the Soligenix corporate presentation is available on the Company s website via this link. ....